Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

CX3CL1/CX3CR1 Axis Contributes to Angiotensin II-Induced Vascular Smooth Muscle Cell Proliferation and Inflammatory Cytokine Production

CX3CL1/CX3CR1 Axis Contributes to Angiotensin II-Induced Vascular Smooth Muscle Cell... Angiotensin II (Ang II) dysregulation has been determined in many diseases. The CX3CL1/CX3CR1 axis, which has a key role in cardiovascular diseases, is involved in the proliferation and inflammatory cytokine production of vascular smooth muscle cells (VSMCs). In this study, we aim to explore whether Ang II has a role in the expression of CX3CL1/CX3CR1, thus contributing to the proliferation and pro-inflammatory status of VSMCs. Cultured mouse aortic VSMCs were stimulated with 100 nmol/L of Ang II, and the expression of CX3CR1 was assessed by western blot. The results demonstrated that Ang II significantly up-regulated CX3CR1 expression in VSMCs and induced the production of reactive oxygen species (ROS) and the phosphorylation of p38 MAPK. Inhibitors of NADPH oxidase, ROS, and AT1 receptor significantly reduced Ang II-induced CX3CR1 expression. Targeted disruption of CX3CR1 by transfection with siRNA significantly attenuated Ang II-induced VSMC proliferation as well as down-regulated the expression of proliferating cell nuclear antigen (PCNA). Furthermore, CX3CR1-siRNA suppressed the effect of Ang II on stimulating Akt phosphorylation. Besides, the use of CX3CR1-siRNA decreased inflammatory cytokine production induced by Ang II treatment. Our results indicate that Ang II up-regulates CX3CR1 expression in VSMCs via NADPH oxidase/ROS/p38 MAPK pathway and that CX3CL1/CX3CR1 axis contributes to the proliferative and pro-inflammatory effects of Ang II in VSMCs. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Inflammation Springer Journals

CX3CL1/CX3CR1 Axis Contributes to Angiotensin II-Induced Vascular Smooth Muscle Cell Proliferation and Inflammatory Cytokine Production

Li, Chengsheng; He, Jin; Zhong, Xiaoyi; Gan, Hua; Xia, Yunfeng
Inflammation , Volume 41 (3) – Jan 22, 2018
Download PDF
11 pages

Loading next page...
 
/lp/springer_journal/cx3cl1-cx3cr1-axis-contributes-to-angiotensin-ii-induced-vascular-08950LzDvW
Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer Science+Business Media, LLC, part of Springer Nature
Subject
Medicine & Public Health; Rheumatology; Internal Medicine; Pharmacology/Toxicology; Pathology
ISSN
0360-3997
eISSN
1573-2576
DOI
10.1007/s10753-018-0736-4
pmid
29356931
Publisher site
See Article on Publisher Site

Abstract

Angiotensin II (Ang II) dysregulation has been determined in many diseases. The CX3CL1/CX3CR1 axis, which has a key role in cardiovascular diseases, is involved in the proliferation and inflammatory cytokine production of vascular smooth muscle cells (VSMCs). In this study, we aim to explore whether Ang II has a role in the expression of CX3CL1/CX3CR1, thus contributing to the proliferation and pro-inflammatory status of VSMCs. Cultured mouse aortic VSMCs were stimulated with 100 nmol/L of Ang II, and the expression of CX3CR1 was assessed by western blot. The results demonstrated that Ang II significantly up-regulated CX3CR1 expression in VSMCs and induced the production of reactive oxygen species (ROS) and the phosphorylation of p38 MAPK. Inhibitors of NADPH oxidase, ROS, and AT1 receptor significantly reduced Ang II-induced CX3CR1 expression. Targeted disruption of CX3CR1 by transfection with siRNA significantly attenuated Ang II-induced VSMC proliferation as well as down-regulated the expression of proliferating cell nuclear antigen (PCNA). Furthermore, CX3CR1-siRNA suppressed the effect of Ang II on stimulating Akt phosphorylation. Besides, the use of CX3CR1-siRNA decreased inflammatory cytokine production induced by Ang II treatment. Our results indicate that Ang II up-regulates CX3CR1 expression in VSMCs via NADPH oxidase/ROS/p38 MAPK pathway and that CX3CL1/CX3CR1 axis contributes to the proliferative and pro-inflammatory effects of Ang II in VSMCs.

Journal

Inflammation – Springer Journals

Published: Jan 22, 2018

References

  • Angiotensin II, NADPH oxidase, and redox signaling in the vasculature
    Cat, AND; Montezano, AC; Burger, D
  • Angiotensin II, aldosterone, and anti-inflammatory lymphocytes: Interplay and therapeutic opportunities
    Kasal, DA; Schiffrin, EL
  • Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells
    Touyz, RM; Schiffrin, EL
  • Angiotensin II and vascular injury
    Montezano, AC; Nguyen, DCA; Rois, FJ
  • Role of smooth muscle cells in the initiation and early progression of atherosclerosis
    Doran, AC; Meller, N; McNamara, CA
  • Prostaglandin D2 synthase inhibits the exaggerated growth phenotype of spontaneously hypertensive rat vascular smooth muscle cells
    Ragolia, L; Palaia, T; Paric, E; Maesaka, JK
  • The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis
    Rudijanto, A
  • Neferine inhibits angiotensin II-induced rat aortic smooth muscle cell proliferation predominantly by downregulating fractalkine gene expression
    Zheng, L; Cao, Y; Liu, S
  • Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1)
    Lucas, AD; Bursill, C; Guzik, TJ; Sadowski, J; Channon, KM; Greaves, DR
  • Fractalkine (CX3CL1) stimulated by nuclear factor kappaB (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway
    Chandrasekar, B; Mummidi, S; Perla, RP
  • Detrimental effect of fractalkine on myocardial ischaemia and heart failure
    Xuan, W; Liao, Y; Chen, B
  • High expression of CX3C chemokine receptor 1 (CX3CR1) in human carotid plaques is associated with vulnerability of the lesions
    Masztalewicz, M; Nowacki, P; Szydłowski, Ł
  • Cross talk between smooth muscle cells and monocytes/activated monocytes via CX3CL1/CX3CR1 axis augments expression of pro-atherogenic molecules
    Butoi, ED; Gan, AM; Manduteanu, I; Stan, D
  • Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease
    Moatti, D; Faure, S; Fumeron, F
  • Upregulation of fractalkine and its receptor, CX3CR1, is associated with coronary plaque rupture in patients with unstable angina pectoris
    Ikejima, H; Imanishi, T; Tsujioka, H
  • Salusin-beta contributes to vascular remodeling associated with hypertension via promoting vascular smooth muscle cell proliferation and vascular fibrosis
    Sun, HJ
  • Inhibitory effects of enalaprilat on rat cardiac fibroblast proliferation via ROS/P38MAPK/TGF-β1 signaling pathway
    Yu, M; Zheng, Y; Sun, HX; Yu, DJ
  • Measurement of reactive oxygen species in cardiovascular disease
    Khan, M; Hassan, F; Roy, S
  • The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases
    Cai, H; Griendling, KK; Harrison, DG
  • Inflammatory effects of resistin on human smooth muscle cells: Up-regulation of fractalkine and its receptor, CX3CR1 expression by TLR4 and Gi-protein pathways
    Gan, AM; Butoi, ED; Manea, A
  • Enhanced proliferation and migration of vascular smooth muscle cells in response to vascular injury under hyperglycemic conditions is controlled by beta3 integrin signaling
    Panchatcharam, M
  • Fractalkine is expressed by smooth muscle cells in response to IFN-gamma and TNF-alpha and is modulated by metalloproteinase activity
    Ludwig, A; Berkhout, T; Moores, K
  • Phosphatidylinositol 3-kinase-dependent extracellular calcium influx is essential for CX(3)CR1-mediated activation of the mitogen-activated protein kinase cascade
    Kansra, V; Groves, C; Gutierrez Ramos, JC; Polakiewicz, RD
  • Fractalkine upregulates intercellular adhesion molecule-1 in endothelial cells through CX3CR1 and the Jak-Stat5 pathway
    Yang, XP; Jones, RA; Rivers, JH
  • Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signaling
    White, GE; Tan, TCC; John, AE
  • Angiotensin-(1–7) abrogates angiotensin II-induced proliferation, migration and inflammation in VSMCs through inactivation of ROS-mediated PI3K/Akt and MAPK/ERK signaling pathways
    Zhang, F; Ren, X; Zhao, M
  • Central role of the MAPK pathway in ang II-mediated DNA synthesis and migration in rat vascular smooth muscle cells
    Xi, XP
  • Cardamonin inhibits angiotensin II-induced vascular smooth muscle cell proliferation and migration by downregulating p38 MAPK, Akt, and ERK phosphorylation
    Shen, YJ
  • 3, 4-di-O-Caffeoylquinic acid inhibits angiotensin-II-induced vascular smooth muscle cell proliferation and migration by downregulating the JNK and PI3K/Akt signaling pathways
    Chiou, WF; Chen, C-C; Wei, B-L
  • Enteric flora expands gut lamina propria CX3CR1+ dendritic cells supporting inflammatory immune responses under normal and inflammatory conditions
    Niess, JH; Adler, G
  • Role of CX3C-chemokine CX3C-L/fractalkine expression in a model of slowly progressive renal failure
    Koziolek, MJ; Müller, GA; Zapf, A
  • Dose-dependent differential regulation of cytokine secretion from macrophages by fractalkine
    Mizutani, N; Sakurai, T; Shibata, T